Claudia S. Gunther

Tuebingen, BW 72076, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 236 publications

Does the RESIST score predict 5-year mortality beyond EUSTAR? Validation in the German Network for Systemic Sclerosis.

Does the RESIST score predict 5-year mortality beyond EUSTAR? Validation in the German Network for Systemic Sclerosis.

Journal: Annals of the rheumatic diseases

Published: July 08, 2026

Quantifying the Interplay Between PRAME Expression and Classical Morphology: A Multivariable Analysis of 954 Suspected Melanocytic Lesions.

Quantifying the Interplay Between PRAME Expression and Classical Morphology: A Multivariable Analysis of 954 Suspected Melanocytic Lesions.

Journal: Dermatopathology (Basel, Switzerland)

Published: June 18, 2026

48/f with Raynaud symptoms, telangiectasia and dysphagia : Preparation for the medical specialist examination: part 64

48/f with Raynaud symptoms, telangiectasia and dysphagia : Preparation for the medical specialist examination: part 64

Journal: Dermatologie (Heidelberg, Germany)

Published: June 08, 2026

Lichen sclerosus. Part 2. Guideline of the DGG, DGGG, OEGGG and SGGG (S3-Level, AWMF Registry No. 013-105, July 2025.

Lichen sclerosus. Part 2. Guideline of the DGG, DGGG, OEGGG and SGGG (S3-Level, AWMF Registry No. 013-105, July 2025.

Journal: Geburtshilfe und Frauenheilkunde

Published: April 22, 2026

Lichen sclerosus. Part 1. Guideline of the DGG, DGGG, OEGGG and SGGG (S3-Level, AWMF Registry No. 013-105, July 2025.

Lichen sclerosus. Part 1. Guideline of the DGG, DGGG, OEGGG and SGGG (S3-Level, AWMF Registry No. 013-105, July 2025.

Journal: Geburtshilfe und Frauenheilkunde

Published: April 22, 2026

Real-world treatment patterns and determinants of therapy in systemic sclerosis: findings from the German Network for SSc cohort.

Real-world treatment patterns and determinants of therapy in systemic sclerosis: findings from the German Network for SSc cohort.

Journal: Arthritis research & therapy

Published: March 27, 2026

Csf1r-mediated depletion of myeloid cells prevents dopaminergic neuron loss during chronic colitis.

Csf1r-mediated depletion of myeloid cells prevents dopaminergic neuron loss during chronic colitis.

Journal: Journal of neuroinflammation

Published: February 26, 2026

Detection of bacterial extracellular vesicles in patients with cystic fibrosis - a pilot study.

Detection of bacterial extracellular vesicles in patients with cystic fibrosis - a pilot study.

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

Published: January 22, 2026

Author Correction: E-type prostanoid receptor 4 drives resolution of intestinal inflammation by blocking epithelial necroptosis.

Author Correction: E-type prostanoid receptor 4 drives resolution of intestinal inflammation by blocking epithelial necroptosis.

Journal: Nature cell biology

Published: December 22, 2025

In vitro modeling of inflammatory bowel diseases using a newly developed immunocompetent colon epithelial monolayer co-culture model.

In vitro modeling of inflammatory bowel diseases using a newly developed immunocompetent colon epithelial monolayer co-culture model.

Journal: npj biomedical innovations

Published: December 17, 2025

International development of Investigator Global Assessment scores for pemphigus.

International development of Investigator Global Assessment scores for pemphigus.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: November 27, 2025

The endogenous peptide GPR15L shapes the intestinal microbiota to counteract colitis.

The endogenous peptide GPR15L shapes the intestinal microbiota to counteract colitis.

Journal: Gut

Published: November 21, 2025

Showing 1-12 of 236

Last Updated: 09/26/2026